All Stories

  1. Plasma proteome differences between giant cell arteritis and polymyalgia rheumatica: a pilot study

    Article • Arthritis Research & Therapy, July 2026, Springer Science + Business Media

    Michael Schirmer

  2. Multimodal imaging and molecular analysis of a 350-year-old purple heron mummy

    Article • Scientific Reports, April 2026, Springer Science + Business Media

    Michael Schirmer

  3. Exploratory Cytokine and Bone-Marker Patterns in a Proteoglycan-Induced Spondyloarthritis Mouse Model: Th1/Th2 Strain Comparison and TLR2/3/4 Knockout Readouts

    Article • International Journal of Molecular Sciences, January 2026, MDPI AG

    Michael Schirmer

  4. Can Phagocytosis, Neutrophil Extracellular Traps, and IFN-α Production in Systemic Lupus Erythematosus Be Simultaneously Modulated? A Pharmacological Perspective

    Article • International Journal of Molecular Sciences, January 2026, MDPI AG

    Michael Schirmer

  5. Detection of bone infections using Vis-NIR and SWIR hyperspectral imaging coupled with machine learning

    Article • Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy, January 2026, Elsevier

    Michael Schirmer

  6. Rapid forensic differentiation of human and animal bones using handheld near-infrared spectroscopy and deep learning

    Article • Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy, January 2026, Elsevier

    Michael Schirmer

  7. Increased expression of Toll-like receptors and associated alarmins in temporal arteries of patients with giant cell arteritis

    Article • World Journal of Surgery, November 2025, Springer Science + Business Media

    Michael Schirmer

  8. Advancements in High-Resolution Computed Tomography: Revolutionising Bone Health Micro-Research

    Article • Bioengineering, October 2025, MDPI AG

    Michael Schirmer

  9. Effective detection of staphylococcal infections in human bone tissue using combined raman microscopy and micro-computed tomography

    Article • Frontiers in Bioengineering and Biotechnology, August 2025, Frontiers

    Michael Schirmer

  10. HR-pQCT and 3D Printing for Forensic and Orthopaedic Analysis of Gunshot-Induced Bone Damage

    Article • Biomedicines, July 2025, MDPI AG

    Michael Schirmer

  11. Quality approaches and standards of 3D printing in orthopedic and traumatological settings: a systematic review

    Article • Exploration of Musculoskeletal Diseases, June 2025, Open Exploration Publishing

    Michael Schirmer

  12. Mentalizing, Loneliness and Pain-Related Depressive Symptoms Are Associated with Pain Severity in Patients with Rheumatic Diseases: Results of a Cross-Sectional Secondary Analysis

    Article • Journal of Clinical Medicine, May 2025, MDPI AG

    Michael Schirmer

  13. Bone remodelling after scaphoid fractures: HR-pQCT, clinical and laboratory data from a prospective 1-year follow-up study

    Article • Bone, March 2025, Elsevier

    Michael Schirmer

  14. Reduced Bone Quality of Sacrum and Lumbal Vertebrae Spongiosa in Toll-like Receptor 2- and Toll-like Receptor 4-Knockout Mice: A Blinded Micro-Computerized Analysis

    Article • Biomolecules, February 2025, MDPI AG

    Michael Schirmer

  15. Promoting patients' empowerment in rheumatic diseases: the perspective of the International Society of Behçet's Disease Working Group on Patient Empowerment, Adherence to Therapy and Patients' Education

    Article • Clinical and Experimental Rheumatology, January 2025, Clinical and Experimental Rheumatology

    Michael Schirmer

  16. Murine vs. Human Osteoblast Responses to Coagulation and Inflammatory Factors: Reconsidering the Use of Animal Models in Hemophilia A Research

    Article • Biomedicines, November 2024, MDPI AG

    Michael Schirmer

  17. Raman Handheld Versus Microscopic Spectroscopy for Estimating the Post-Mortem Interval of Human Bones: A Comparative Pilot Study

    Article • Bioengineering, November 2024, MDPI AG

    Michael Schirmer

  18. Symptom Severity and Glucocorticoid Dosing in Patients With Polymyalgia Rheumatica and Obesity

    Article • The Journal of Rheumatology, November 2024, The Journal of Rheumatology

    Michael Schirmer

  19. Calcium pyrophosphate deposition disease: points to be considered for quality assurance in clinical practice

    Article • July 2024, Open Exploration Publishing

    Michael Schirmer

  20. Opportunities of digital health technologies for rheumatology: from clinics to quality and research

    Article • April 2024, Open Exploration Publishing

    Michael Schirmer

  21. Deep Convolutional Neural Networks Provide Motion Grading for High-Resolution Peripheral Quantitative Computed Tomography of the Scaphoid

    Article • Diagnostics, March 2024, MDPI AG

    Michael Schirmer

  22. Long-Term Comparison of Two- and Three-Dimensional Computed Tomography Analyses of Cranial Bone Defects in Severe Parietal Thinning

    Article • Diagnostics, February 2024, MDPI AG

    Michael Schirmer

  23. Handheld hyperspectral imaging as a tool for the post-mortem interval estimation of human skeletal remains

    Article • Heliyon, February 2024, Elsevier

    Michael Schirmer

  24. Enhancing Bone Infection Diagnosis with Raman Handheld Spectroscopy: Pathogen Discrimination and Diagnostic Potential

    Article • International Journal of Molecular Sciences, December 2023, MDPI AG

    Michael Schirmer

  25. Eye Disease in Patients with Rheumatic Diseases: A Retrospective Observational Cohort Study

    Article • Journal of Clinical Medicine, December 2023, MDPI AG

    Michael Schirmer

  26. Personalized therapy in rheumatoid arthritis (PETRA): a protocol for a randomized controlled trial to test the effect of a psychological intervention in rheumatoid arthritis

    Article • Trials, November 2023, Springer Science + Business Media

    Michael Schirmer

  27. SARS-CoV-2 activates the TLR4/MyD88 pathway in human macrophages: A possible correlation with strong pro-inflammatory responses in severe COVID-19

    Article • Heliyon, November 2023, Elsevier

    Michael Schirmer

  28. Unexpected High Need for Genetic Testing in Rheumatology: A Cross-Sectional Cohort Study

    Article • Genes, September 2023, MDPI AG

    Michael Schirmer

  29. Comparison of Mid-Infrared Handheld and Benchtop Spectrometers to Detect Staphylococcus epidermidis in Bone Grafts

    Article • Bioengineering, August 2023, MDPI AG

    Michael Schirmer

  30. Raman spectroscopy for postmortem interval estimation of human skeletal remains: A scoping review

    Article • Journal of Biophotonics, August 2023, Wiley

    Michael Schirmer

  31. Loss or Dilution—A New Diagnostic Method to Assess the Impact of Dilution on Standard Laboratory Parameters

    Article • Diagnostics, August 2023, MDPI AG

    Michael Schirmer

  32. Goodbye to a great clinician, scientist and role model: Winfried Graninger (1956–2023)

    Article • Wiener klinische Wochenschrift, August 2023, Springer Science + Business Media

    Michael Schirmer

  33. Erinnerungen an Winfried Graninger

    Article • Zeitschrift für Rheumatologie, July 2023, Springer Science + Business Media

    Michael Schirmer

  34. Long-Term Comparison of Two- and Three-Dimensional Computed Tomography Analyses of Cranial Bone Defects in Severe Parietal Thinning

    Article • April 2023, MDPI AG

    Michael Schirmer

  35. Improved social functioning and role functioning in rheumatic patients using a non-verbal communication tool: Results from a randomized, double-blind, controlled pilot-study

    Article • Frontiers in Medicine, April 2023, Frontiers

    Michael Schirmer

  36. Morphological and Tissue Characterization with 3D Reconstruction of a 350-Year-Old Austrian Ardea purpurea Glacier Mummy

    Article • Biology, January 2023, MDPI AG

    Michael Schirmer

  37. Clinical Trials in Chronic Arthritic Diseases with Underestimated Impact of Placebo Effects on Study Size Calculation

    Article • Journal of Clinical Medicine, January 2023, MDPI AG

    Michael Schirmer

  38. Common variable immunodeficiency with granulomatous‐lymphocytic interstitial lung disease treated with monoclonal antibodies against COVID‐19: A case report

    Article • Clinical Case Reports, January 2023, Wiley

    Michael Schirmer

  39. Optimization of the Alizarin Red S Assay by Enhancing Mineralization of Osteoblasts

    Article • International Journal of Molecular Sciences, December 2022, MDPI AG

    Michael Schirmer

  40. Indications for diagnostic use of nuclear medicine in rheumatology: A mini-review

    Article • Frontiers in Medicine, September 2022, Frontiers

    Michael Schirmer

  41. Application of Micro-Computed Tomography for the Estimation of the Post-Mortem Interval of Human Skeletal Remains

    Article • Biology, July 2022, MDPI AG

    Michael Schirmer

  42. Post-Mortem Interval of Human Skeletal Remains Estimated with Handheld NIR Spectrometry

    Article • Biology, July 2022, MDPI AG

    Michael Schirmer

  43. Immunological Memory and Affinity Maturation After Vaccination in Patients With Propionic Acidemia

    Article • Frontiers in Immunology, March 2022, Frontiers

    Michael Schirmer

  44. Cardiovascular Risks and Risk Stratification in Inflammatory Joint Diseases: A Cross-Sectional Study

    Article • Frontiers in Medicine, February 2022, Frontiers

    Michael Schirmer

  45. Placebo-Related Adverse Events in Rheumatoid Arthritis

    Article • Biomolecules, February 2022, MDPI AG

    Michael Schirmer

  46. Low Bone Mineral Density in Hemophiliacs

    Article • Frontiers in Medicine, February 2022, Frontiers

    Michael Schirmer

  47. Identification of Five Quality Needs for Rheumatology (Text Analysis and Literature Review)

    Article • Frontiers in Medicine, October 2021, Frontiers

    Michael Schirmer

  48. Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial spondyloarthritis

    Article • Rheumatology, September 2021, Oxford University Press (OUP)

    Michael Schirmer

  49. Rasch Model of the COVID-19 Symptom Checklist—A Psychometric Validation Study

    Article • Viruses, September 2021, MDPI AG

    Michael Schirmer

  50. Adamantiades‐Behçet's disease (Behçet's disease) and COVID‐19

    Article • Journal of the European Academy of Dermatology and Venereology, May 2021, Wiley

    Michael Schirmer

  51. Rasch Model of the COVID-19 Symptom Checklist - Towards a Higher Quality of Self-Reported Measurement

    Article • February 2021, Springer Science + Business Media

    Michael Schirmer

  52. Editorial

    Article • JCR Journal of Clinical Rheumatology, January 2021, Wolters Kluwer Health

    Michael Schirmer

  53. Hyperspectral imaging as a diagnostic tool to differentiate between amalgam tattoos and other dark pigmented intraoral lesions

    Article • Journal of Biophotonics, November 2020, Wiley

    Michael Schirmer

  54. Polypharmacy in Middle-European Rheumatoid Arthritis-Patients: A Retrospective Longitudinal Cohort Analysis With Systematic Literature Review

    Article • Frontiers in Medicine, November 2020, Frontiers

    Michael Schirmer

  55. Personalized Medicine in Austria: Expectations and Limitations

    Article • Personalized Medicine, October 2020, Taylor & Francis

    Michael Schirmer

  56. The future of pathology is digital

    Article • Pathology - Research and Practice, September 2020, Elsevier

    Michael Schirmer

  57. Comparison of structure and composition of a fossil Champsosaurus vertebra with modern Crocodylidae vertebrae: A multi-instrumental approach

    Article • Journal of the Mechanical Behavior of Biomedical Materials, April 2020, Elsevier

    Michael Schirmer

  58. CD28 and CD57 define four populations with distinct phenotypic properties within human CD8 + T cells

    Article • European Journal of Immunology, March 2020, Wiley

    Michael Schirmer

  59. Management and Comorbidities in Middle-European Patients with Rheumatoid Arthritis: A Retrospective, Cross-sectional Comparison with COMORA Data

    Article • The Open Rheumatology Journal, December 2019, Bentham Science Publishers

    Michael Schirmer

  60. Author response for "CD28 and CD57 Define four populations with distinct phenotypic properties within human CD8 <sup>+</sup> T cells"

    Article • October 2019, Wiley

    Michael Schirmer

  61. Correction to: Nurses’ roles in the management of chronic inflammatory arthritis: a systematic review

    Article • Rheumatology International, August 2019, Springer Science + Business Media

    Michael Schirmer

  62. 2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis

    Article • Annals of the Rheumatic Diseases, July 2019, BMJ

    Michael Schirmer

  63. Clinical infrared microscopic imaging: An overview

    Article • Pathology - Research and Practice, October 2018, Elsevier

    Michael Schirmer

  64. Nurses’ roles in the management of chronic inflammatory arthritis: a systematic review

    Article • Rheumatology International, August 2018, Springer Science + Business Media

    Michael Schirmer

  65. Validierung der deutschen Version des ASAS-Gesundheitsindex

    Article • Zeitschrift für Rheumatologie, July 2018, Springer Science + Business Media

    Michael Schirmer

  66. Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis

    Article • Annals of the Rheumatic Diseases, June 2018, BMJ

    Michael Schirmer, Prof Tuncay Duruöz

  67. Tocilizumab for the treatment of giant cell arteritis

    Article • Expert Review of Clinical Immunology, May 2018, Taylor & Francis

    Michael Schirmer

  68. Differential clinical presentation of Adamantiades-Behçet's disease in non-endemic and endemic areas: retrospective data from a Middle-European cohort study

    Article • International Journal of Rheumatic Diseases, April 2018, Wiley

    Michael Schirmer

  69. FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC

    Article • European Journal of Pediatrics, April 2018, Springer Science + Business Media

    Michael Schirmer, Alberto Signore

  70. Rheumatologie in Österreich

    Article • Zeitschrift für Rheumatologie, March 2018, Springer Science + Business Media

    Michael Schirmer

  71. Checklist for selecting items of electronic health records

    Article • Health Services Research and Managerial Epidemiology, January 2018, SAGE Publications

    Michael Schirmer

  72. Subgrouping fibromyalgia according to prevalence data may lead to a new therapeutic concept

    Article • Rheumatology International, October 2017, Springer Science + Business Media

    Michael Schirmer

  73. Decline of rheumatologic care of nursing home residents with rheumatoid arthritis

    Article • Rheumatology International, September 2017, Springer Science + Business Media

    Michael Schirmer

  74. FRI0338 Therapeutic conformity to guidelines and drug-approval in adamantiades-behcet's disease: a retrospective analysis of a middle-european cohort

    Article • June 2017, BMJ

    Michael Schirmer

  75. Proposal for an Urgency Score as General Referral Strategy to Second- Care Rheumatology

    Article • Annals of Musculoskeletal Medicine, February 2017, Peertechz.com

    Michael Schirmer

  76. Deutsche Übersetzung und krosskulturelle Adaptation des ASAS-Gesundheitsindex

    Article • Zeitschrift für Rheumatologie, October 2016, Springer Science + Business Media

    Michael Schirmer

  77. Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages

    Article • RMD Open, October 2016, BMJ

    Michael Schirmer, Prof Tuncay Duruöz

  78. Booster vaccination against tetanus and diphtheria: insufficient protection against diphtheria in young and elderly adults

    Article • Immunity & Ageing, September 2016, Springer Science + Business Media

    Michael Schirmer

  79. Immunsystem und rheumatische Erkrankungen im Alter

    Article • DMW - Deutsche Medizinische Wochenschrift, June 2016, Thieme Publishing Group

    Michael Schirmer

  80. Subgrouping fibromyalgia patients according to response to therapeutic interventions: a new concept for a disease with low treatment-response rates

    Article • Rheumatology International, December 2015, Springer Science + Business Media

    Michael Schirmer

  81. 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

    Article • Annals of the Rheumatic Diseases, September 2015, BMJ

    Dr Ajesh AB Maharaj , Michael Schirmer

  82. 2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative

    Article • Arthritis & Rheumatology, September 2015, Wiley

    Dr Ajesh AB Maharaj , Michael Schirmer

  83. Polymyalgia rheumatica: strategies for efficient practice and quality assurance

    Article • Rheumatology International, June 2015, Springer Science + Business Media

    Michael Schirmer

  84. Premature senescence of T-cell subsets in axial spondyloarthritis

    Article • Annals of the Rheumatic Diseases, February 2015, BMJ

    Michael Schirmer

  85. Corrigendum to “The Story of CD4+CD28−T Cells Revisited: Solved or Still Ongoing?”

    Article • Journal of Immunology Research, January 2015, Hindawi Publishing Corporation

    Michael Schirmer

  86. The Story of CD4+CD28−T Cells Revisited: Solved or Still Ongoing?

    Article • Journal of Immunology Research, January 2015, Hindawi Publishing Corporation

    Michael Schirmer

  87. Empfehlungen der Österreichische Gesellschaft für Rheumatologie und Rehabilitation/Austrian Radiology-Rheumatology Initiative for Musculoskeletal Ultrasound zur Anwendung des Ultraschalls bei rheumatischen Erkrankungen in der klinischen Praxis

    Article • Wiener klinische Wochenschrift, October 2014, Springer Science + Business Media

    Michael Schirmer

  88. Häufigkeit, Diagnose und Therapie von Rezidiven bei der Polymyalgia rheumatica

    Article • Aktuelle Rheumatologie, August 2014, Thieme Publishing Group

    Michael Schirmer

  89. Klassifikationskriterien und Methoden zur Erfassung der Krankheitsaktivität bei der Polymyalgia rheumatica

    Article • Aktuelle Rheumatologie, August 2014, Thieme Publishing Group

    Michael Schirmer

  90. 5. Biomarkers in PMR, GCA and other large vessel arteritides

    Article • Rheumatology, July 2014, Oxford University Press (OUP)

    Michael Schirmer

  91. Antiphospholipid Antibodies Predict Progression of Abdominal Aortic Aneurysms

    Article • PLOS One, June 2014, PLOS

    Michael Schirmer

  92. Recall Responses to Tetanus and Diphtheria Vaccination Are Frequently Insufficient in Elderly Persons

    Article • PLOS One, December 2013, PLOS

    Michael Schirmer

  93. Clinical implementation of musculoskeletal ultrasound in rheumatology in Austria

    Article • Rheumatology International, September 2013, Springer Science + Business Media

    Michael Schirmer

  94. The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria

    Article • Journal of the European Academy of Dermatology and Venereology, February 2013, Wiley

    Dr Thrasivoulos Tzellos, Michael Schirmer

  95. NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica

    Article • Annals of the Rheumatic Diseases, February 2013, BMJ

    Michael Schirmer

  96. Elderly- versus younger-onset rheumatoid arthritis: Higher levels of ultrasound-detected inflammation despite comparable clinical disease activity

    Article • Arthritis Care & Research, January 2013, Wiley

    Michael Schirmer

  97. Riesenzellarteritis

    Article • Zeitschrift für Rheumatologie, November 2012, Springer Science + Business Media

    Michael Schirmer

  98. Ultrasound-Defined Remission and Active Disease in Rheumatoid Arthritis: Association with Clinical and Serologic Parameters

    Article • Seminars in Arthritis and Rheumatism, June 2012, Elsevier

    Michael Schirmer

  99. Apoptotic Effects of Antilymphocyte Globulins on Human Pro-inflammatory CD4+CD28− T-cells

    Article • PLOS One, March 2012, PLOS

    Michael Schirmer

  100. Patient-reported Outcomes in Polymyalgia Rheumatica

    Article • The Journal of Rheumatology, March 2012, The Journal of Rheumatology

    Michael Schirmer

  101. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

    Article • Annals of the Rheumatic Diseases, March 2012, BMJ

    Michael Schirmer

  102. 2012 Provisional classification criteria for polymyalgia rheumatica: A European League Against Rheumatism/American College of Rheumatology collaborative initiative

    Article • Arthritis & Rheumatism, March 2012, Wiley

    Michael Schirmer

  103. Erwartungen des Rheumatologen an die Bildgebung

    Article • Der Radiologe, February 2012, Springer Science + Business Media

    Michael Schirmer

  104. Ist es eine Polymyalgia rheumatica?

    Article • MMW - Fortschritte der Medizin, January 2012, Springer Science + Business Media

    Michael Schirmer

  105. Abdominal Aortic Aneurysms

    Article • Journal of Primary Care & Community Health, November 2011, SAGE Publications

    Michael Schirmer

  106. Post-thymic regulation of CD5 levels in human memory T cells is inversely associated with the strength of responsiveness to interleukin-15

    Article • Human Immunology, August 2011, Elsevier

    Dr Daniela Weiskopf, Michael Schirmer

  107. Polymyalgia rheumatica and giant cell arteritis: management of two diseases of the elderly

    Article • Aging Health, August 2011, Future Medicine

    Michael Schirmer

  108. Ultrasonography in inflammatory rheumatic disease: an overview

    Article • Nature Reviews Rheumatology, July 2011, Springer Science + Business Media

    Michael Schirmer

  109. Investigation of bacterial and viral agents and immune status in Behcet’s disease patients from Iran

    Article • International Journal of Rheumatic Diseases, March 2011, Wiley

    Michael Schirmer

  110. Editorial [Hot Topic: Aging and Immune-Mediated Diseases (Guest Editors: Christian Dejaco, Christina Duftner and Michael Schirmer)]

    Article • Current Immunology Reviews, February 2011, Bentham Science Publishers

    Michael Schirmer

  111. Early Aged T-Cells in Immune-Mediated Diseases

    Article • Current Immunology Reviews, February 2011, Bentham Science Publishers

    Michael Schirmer

  112. Similar performance of DAS-28, CDAI, and SDAI in rheumatoid arthritis patients with and without sonographic signs of active inflammation in routine clinical practice

    Article • Scandinavian Journal of Rheumatology, January 2011, Taylor & Francis

    Michael Schirmer

  113. Major vessel involvement in Behçetʼs disease: an update

    Article • Current Opinion in Rheumatology, January 2011, Wolters Kluwer Health

    Michael Schirmer

  114. Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus

    Article • Annals of the Rheumatic Diseases, November 2010, BMJ

    Michael Schirmer

  115. Neopterin: Marker of coronary artery disease activity, severity and/or extent in patients with clinically stable angina?

    Article • International Journal of Cardiology, September 2010, Elsevier

    Michael Schirmer

  116. Fusion of Real-time US with CT Images to Guide Sacroiliac Joint Injection in Vitro and in Vivo

    Article • Radiology, August 2010, Radiological Society of North America (RSNA)

    Michael Schirmer

  117. Problemfelder in der Schmerzmessung und Schmerztherapie im Alter

    Article • Wiener Medizinische Wochenschrift, May 2010, Springer Science + Business Media

    Michael Schirmer

  118. Detection of vascularity in wrist tenosynovitis: power Doppler ultrasound compared to contrast-enhanced grey-scale ultrasound

    Article • Arthritis Research & Therapy, January 2010, Springer Science + Business Media

    Michael Schirmer

  119. Rheumatologie

    Article • January 2010, Springer Science + Business Media

    Michael Schirmer

  120. The use of tumour necrosis factor alpha-blockers in daily routine. An Austrian consensus project

    Article • Clinical Rheumatology, November 2009, Springer Science + Business Media

    Michael Schirmer

  121. Third generation anti-cyclic citrullinated peptide antibodies do not predict anti-TNF-α treatment response in rheumatoid arthritis

    Article • Rheumatology International, June 2009, Springer Science + Business Media

    Michael Schirmer

  122. 13th International Conference on Behçet’s Disease, May 24–27, 2008, Pörtschach am Wörthersee, Austria

    Article • The Journal of Rheumatology, June 2009, The Journal of Rheumatology

    Michael Schirmer

  123. Möglichkeiten der Krankheitsaktivitätsmessung bei Vaskulitiden im klinischen Alltag

    Article • Aktuelle Rheumatologie, June 2009, Thieme Publishing Group

    Michael Schirmer

  124. Neopterin, CD4+CD28− lymphocytes and the extent and severity of coronary artery disease

    Article • International Journal of Cardiology, June 2009, Elsevier

    Michael Schirmer

  125. Altered T-cell subtypes in spondyloarthritis, rheumatoid arthritis and polymyalgia rheumatica

    Article • Rheumatology International, May 2009, Springer Science + Business Media

    Michael Schirmer

  126. Aktuelle Therapieansätze bei Riesenzellarteriitis

    Article • Zeitschrift für Rheumatologie, February 2009, Springer Science + Business Media

    Michael Schirmer

  127. An outbreak of norovirus gastroenteritis in an Austrian hospital, winter 2006–2007

    Article • Wiener klinische Wochenschrift, February 2009, Springer Science + Business Media

    Professor Franz Allerberger, Michael Schirmer

  128. Neue Option in der Behandlung der rheumatoiden Arthritis: Abatacept, ein selektiver Modulator der T-Zell-Kostimulation

    Article • Wiener Medizinische Wochenschrift, February 2009, Springer Science + Business Media

    Michael Schirmer

  129. Antibodies against mutated citrullinated vimentin fail to predict anti‐TNFα treatment response in rheumatoid arthritis

    Article • Scandinavian Journal of Rheumatology, January 2009, Taylor & Francis

    Michael Schirmer

  130. Polymyalgia rheumatica

    Article • Der Internist, December 2008, Springer Science + Business Media

    Michael Schirmer

  131. Empfehlungen der European League Against Rheumatism (EULAR) zur Behandlung von „Großgefäßvaskulitiden“

    Article • Zeitschrift für Rheumatologie, December 2008, Springer Science + Business Media

    Michael Schirmer

  132. Feasibility of ultrasound-guided sacroiliac joint injection considering sonoanatomic landmarks at two different levels in cadavers and patients

    Article • Arthritis & Rheumatism, November 2008, Wiley

    Michael Schirmer

  133. Reply

    Article • Arthritis Care & Research, September 2008, Wiley

    Michael Schirmer

  134. Diagnose und Therapie neurologischer Manifestationen bei entzündlich-rheumatischen Erkrankungen

    Article • Zeitschrift für Rheumatologie, August 2008, Springer Science + Business Media

    Michael Schirmer

  135. 4 years after withdrawal of rofecoxib: where do we stand today?

    Article • Rheumatology International, July 2008, Springer Science + Business Media

    Michael Schirmer

  136. Biologicals in rheumatology: Austrian experiences from a rheumatic outpatient clinic

    Article • Rheumatology International, July 2008, Springer Science + Business Media

    Michael Schirmer

  137. Biologicals in rheumatology: Austrian experiences from a rheumatic outpatient clinic

    Article • Rheumatology International, May 2008, Springer Science + Business Media

    Michael Schirmer

  138. Bildgebende Verfahren in der Frühphase des Morbus Bechterew

    Article • Wiener Medizinische Wochenschrift, May 2008, Springer Science + Business Media

    Michael Schirmer

  139. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etaner...

    Article • Annals of the Rheumatic Diseases, November 2007, BMJ

    Michael Schirmer

  140. Value of contrast-enhanced ultrasound in rheumatoid arthritis

    Article • European Journal of Radiology, November 2007, Elsevier

    Michael Schirmer

  141. Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations

    Article • Rheumatology, March 2007, Oxford University Press (OUP)

    Michael Schirmer

  142. Use of the European preliminary criteria, the Breiman-classification tree and the American–European criteria for diagnosis of primary Sjögren’s Syndrome in daily practice: a retrospective analysis

    Article • Rheumatology International, January 2007, Springer Science + Business Media

    Michael Schirmer

  143. Lack of microbial DNA in tissue specimens of patients with abdominal aortic aneurysms and positive Chlamydiales serology

    Article • European Journal of Clinical Microbiology & Infectious Diseases, January 2007, Springer Science + Business Media

    Professor Doris Wilflingseder, Michael Schirmer

  144. Remitting seronegative syndrome with pitting edema as the presenting symptom in a young, male patient with sarcoidosis: A case report

    Article • Arthritis & Rheumatism, January 2007, Wiley

    Michael Schirmer

  145. Increasing Evidence for Immune-Mediated Processes and New Therapeutic Approaches in Abdominal Aortic Aneurysms--A Review

    Article • Annals of the New York Academy of Sciences, November 2006, Wiley

    Michael Schirmer

  146. 18F-Flourodeoxyglucose positron emission tomography in polymyalgia rheumatica: novel insight into complex pathogenesis but questionable use in predicting relapses

    Article • Rheumatology, October 2006, Oxford University Press (OUP)

    Michael Schirmer

  147. Lack of influence of body mass index on efficacy and tolerance of acemetacin in short-term treatment of musculoskeletal diseases

    Article • Rheumatology International, September 2006, Springer Science + Business Media

    Michael Schirmer

  148. Induction of Tolerance in Autoimmune Diseases Rather Than Cure of Cancer by Interleukin-2 Therapy

    Article • Journal of Clinical Oncology, July 2006, American Society of Clinical Oncology (ASCO)

    Michael Schirmer

  149. Kontrastmittelverstärkte Sonographie bei rheumatischen Gelenkerkrankungen

    Article • Aktuelle Rheumatologie, June 2006, Thieme Publishing Group

    Michael Schirmer

  150. Preferential type 1 chemokine receptors and cytokine production of CD28- T cells in ankylosing spondylitis

    Article • Annals of the Rheumatic Diseases, May 2006, BMJ

    Michael Schirmer

  151. Sonographie synovialer und erosiver entzündlicher Veränderungen

    Article • Der Radiologe, May 2006, Springer Science + Business Media

    Michael Schirmer

  152. Positive and negative predictive values from published studies can be misleading for decision-making in clinical practice: reply

    Article • Rheumatology, April 2006, Oxford University Press (OUP)

    Michael Schirmer

  153. Are regulatory T-cells linked with aging?

    Article • Experimental Gerontology, April 2006, Elsevier

    Michael Schirmer

  154. Imbalance of regulatory T cells in human autoimmune diseases

    Article • Immunology, March 2006, Wiley

    Michael Schirmer

  155. CD8 + T-Cell Subpopulations in Human Abdominal Aortic Aneurysm Lesion

    Article • Arteriosclerosis Thrombosis and Vascular Biology, February 2006, Wolters Kluwer Health

    Michael Schirmer

  156. Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease—A randomized, placebo-controlled study

    Article • American Heart Journal, January 2006, Elsevier

    Michael Schirmer

  157. Abdominal aortic aneurysms: an underestimated type of immune-mediated large vessel arteritis?

    Article • Current Opinion in Rheumatology, January 2006, Wolters Kluwer Health

    Michael Schirmer

  158. Article • Arthritis Research & Therapy, January 2006, Springer Science + Business Media

    Michael Schirmer

  159. To the editor - Eur. J. Immunol. 1/2006

    Article • European Journal of Immunology, January 2006, Wiley

    Michael Schirmer

  160. Tryptophan degradation increases with stage in patients with rheumatoid arthritis

    Article • Clinical Rheumatology, November 2005, Springer Science + Business Media

    Michael Schirmer

  161. High positive predictive value of specific antibodies cross-reacting with a 28-kDa Drosophila antigen for diagnosis of ankylosing spondylitis

    Article • Rheumatology, September 2005, Oxford University Press (OUP)

    Michael Schirmer

  162. Contrast enhanced gray-scale sonography in assessment of joint vascularity in rheumatoid arthritis: results from the IACUS study group

    Article • European Radiology, August 2005, Springer Science + Business Media

    Michael Schirmer

  163. Reduced aortic elastic properties in a child with Takayasu arteritis: case report and literature review

    Article • European Journal of Pediatrics, July 2005, Springer Science + Business Media

    Michael Schirmer

  164. PP21. ANOMALOUS EXPRESSION OF TOLL-LIKE RECEPTORS ON CD4+CD28NULL T-CELLS PROMOTES INTERFERON-γ PRODUCTION IN GIANT CELL ARTERITIS/POLYMYALGIA RHEUMATICA

    Article • Rheumatology, July 2005, Oxford University Press (OUP)

    Michael Schirmer

  165. High Prevalence of Circulating CD4 + CD28 − T-Cells in Patients With Small Abdominal Aortic Aneurysms

    Article • Arteriosclerosis Thrombosis and Vascular Biology, July 2005, Wolters Kluwer Health

    Michael Schirmer

  166. Article • Arthritis Research & Therapy, January 2005, Springer Science + Business Media

    Michael Schirmer

  167. Inflammatory low back pain: High negative predictive value of contrast-enhanced color Doppler ultrasound in the detection of inflamed sacroiliac joints

    Article • Arthritis & Rheumatism, January 2005, Wiley

    Michael Schirmer

  168. Major vessel involvement in Beh??et disease

    Article • Current Opinion in Rheumatology, January 2005, Wolters Kluwer Health

    Michael Schirmer

  169. Remitting seronegative symmetrical synovitis with pitting edema of the hands: Ultrasound, color doppler ultrasound, and magnetic resonance imaging findings

    Article • Arthritis & Rheumatism, January 2005, Wiley

    Michael Schirmer

  170. Quantitative assessment of periarticular osteopenia in patients with early rheumatoid arthritis: a preliminary report

    Article • Scandinavian Journal of Rheumatology, October 2004, Taylor & Francis

    Michael Schirmer

  171. Therapeutic effects of gemcitabine on cutaneous manifestations in an Adamantiades-Behcet's disease-like mouse model

    Article • Experimental Dermatology, October 2004, Wiley

    Michael Schirmer

  172. Aktuelle diagnostische Aspekte beim asymptomatischen Bauchaortenaneurysma

    Article • Gefässchirurgie, August 2004, Springer Science + Business Media

    Michael Schirmer

  173. Venous thromboembolism in long-distance air travellers

    Article • The Lancet, March 2004, Elsevier

    Michael Schirmer

  174. Letter to the Editor

    Article • European Radiology, March 2004, Springer Science + Business Media

    Michael Schirmer

  175. Valvular Disease and Myocardial Infarctions in a Patient With Beh??et Disease

    Article • JCR Journal of Clinical Rheumatology, October 2003, Wolters Kluwer Health

    Michael Schirmer

  176. Fibromyalgia may mask onset of autoimmune diseases

    Article • European Journal of Pain, June 2003, Wiley

    Michael Schirmer

  177. Lymphknotentuberkulose bei Polymyalgie-ähnlichem Syndrom: Wert der 18F-Fluorodeoxyglucose Positron Emissions Tomographie (18F-FDG-PET)

    Article • Zeitschrift für Rheumatologie, June 2003, Springer Science + Business Media

    Michael Schirmer

  178. 18F-Fluorodeoxyglucose-positron emission tomography: A new explorative perspective

    Article • Experimental Gerontology, April 2003, Elsevier

    Michael Schirmer

  179. Generalized Large Vessel Arteritis Visualized by 18 Fluorodeoxyglucose-Positron Emission Tomography

    Article • Circulation, February 2003, Wolters Kluwer Health

    Michael Schirmer

  180. Splinting vs Surgery for Carpal Tunnel SyndromeSplinting vs Surgery for Carpal Tunnel Syndrome

    Article • JAMA, January 2003, American Medical Association (AMA)

    Michael Schirmer

  181. Splinting vs Surgery for Carpal Tunnel Syndrome

    Article • JAMA, January 2003, American Medical Association (AMA)

    Michael Schirmer

  182. Article • Arthritis Research, January 2003, Springer Science + Business Media

    Michael Schirmer

  183. Article • Arthritis Research, January 2003, Springer Science + Business Media

    Michael Schirmer

  184. Article • Arthritis Research, January 2003, Springer Science + Business Media

    Michael Schirmer

  185. Vascular Endothelial Growth Factor (VEGF) in Ankylosing Spondylitis - a Pilot Study

    Article • Wiener Medizinische Wochenschrift, May 2002, Wiley

    Michael Schirmer

  186. The value of contrast-enhanced color doppler ultrasound in the detection of vascularization of finger joints in patients with rheumatoid arthritis

    Article • Arthritis & Rheumatism, March 2002, Wiley

    Michael Schirmer

  187. Article • Arthritis Research, January 2002, Springer Science + Business Media

    Michael Schirmer

  188. Clonality and Longevity of CD4+CD28null T Cells Are Associated with Defects in Apoptotic Pathways

    Article • The Journal of Immunology, December 2000, The American Association of Immunologists

    Michael Schirmer

  189. New Rearrangement Pattern after Treatment of Hairy-Cell Leukemia with 2-Chlorodeoxyadenosine

    Article • Acta Haematologica, January 2000, Karger Publishers

    Michael Schirmer

  190. Differential effects of cladribine and gemcitabine on erythroid and granulocytic progenitors from patients with chronic myeloid leukemia

    Article • Leukemia Research, December 1999, Elsevier

    Michael Schirmer

  191. GEMCITABINE-A NOVEL IMMUNOSUPPRESSIVE AGENT-PREVENTS REJECTION IN A RAT CARDIAC TRANSPLANTATION MODEL1

    Article • Transplantation, October 1999, Wolters Kluwer Health

    Michael Schirmer

  192. Severe deep white matter lesions and outcome in major depressive disorder

    Article • BMJ, March 1999, BMJ

    Michael Schirmer

  193. Entamoeba hartmanni: a new causative agent in the pathogenesis of reactive arthritis?

    Article • Rheumatology International, June 1998, Springer Science + Business Media

    Michael Schirmer

  194. Aging-related Deficiency of CD28 Expression in CD4+ T Cells Is Associated with the Loss of Gene-specific Nuclear Factor Binding Activity

    Article • Journal of Biological Chemistry, April 1998, American Society for Biochemistry & Molecular Biology (ASBMB)

    Michael Schirmer

  195. Antitumor effect of the nucleoside analogs 2-chlorodeoxyadenosine and 2′,2′-difluorodeoxycytidine on human hepatoma HepG2 cells

    Article • Journal of Hepatology, March 1998, Elsevier

    Michael Schirmer

  196. A Comparison of the Antiproliferative Properties of Recombinant Human IFN-α2 and IFN-ω in Human Bone Marrow Culture

    Article • Journal of Interferon & Cytokine Research, June 1997, Mary Ann Liebert Inc

    Michael Schirmer

  197. Active compression–decompression cardiopulmonary resuscitation in standing position over the patient: pros and cons of a new method

    Article • Resuscitation, February 1997, Elsevier

    Michael Schirmer

  198. The Safety Profile of Low-dose Cladribine in Refractory Rheumatoid Arthritis

    Article • Scandinavian Journal of Rheumatology, January 1997, Taylor & Francis

    Michael Schirmer

  199. T Cells and Natural Killer Cells after Treatment of Hairy Cell Leukaemia with 2-Chlorodeoxyadenosine

    Article • Acta Haematologica, January 1997, Karger Publishers

    Michael Schirmer

  200. Rescuer's work capacity and duration of cardiopulmonary resuscitation

    Article • Resuscitation, December 1996, Elsevier

    Michael Schirmer

  201. Local application of antimycotics in mucormycosis cerebri: a case report.

    Article • Journal of Neurology Neurosurgery & Psychiatry, November 1996, BMJ

    Michael Schirmer

  202. Inhibitory effects of the nucleoside analogue gemcitabine on prostatic carcinoma cells

    Article • The Prostate, March 1996, Wiley

    Michael Schirmer

  203. Acyclovir in acute oligoarticular herpetic arthritis

    Article • The Lancet, September 1995, Elsevier

    Michael Schirmer

  204. Minimal Residual Disease in Hairy-cell Leukemia after Treatment with 2-chlorodeoxyadenosine

    Article • Blood Cells Molecules and Diseases, August 1995, Elsevier

    Michael Schirmer

  205. The immunosuppressive substance 2-chloro-2-deoxyadenosine modulates lipoprotein metabolism in a murine macrophage cell line (P388 cells)

    Article • Lipids, September 1994, Wiley

    Michael Schirmer

  206. Fulminant hepatitis C virus infection

    Article • The Lancet, June 1994, Elsevier

    Michael Schirmer